# Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection

> **NCT03973697** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 9 (actual)

## Conditions studied

- Recurrent Clostridium Difficile Infection

## Interventions

- **DRUG:** Penn Microbiome Therapy - 001
- **DRUG:** Penn Microbiome Therapy - 002
- **DRUG:** Penn Microbiome Therapy - 003

## Key facts

- **NCT ID:** NCT03973697
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-13
- **Primary completion:** 2021-08-11
- **Final completion:** 2021-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Administrative reasons
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03973697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03973697, "Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03973697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*